Object Pharma, Inc.

0 followers

Developing botulinum neurotoxins for unmet needs in aesthetic and therapeutic markets.

Employees

1-10

Links


Org chart

Kenton Abel
Chief Executive Officer
Collapse
Dan Radecki
Vice President Of Research And Development
Dale Hollingshead
Chief Financial Officer
Eric C.
Vice President Product Development
Le'Kneitah Smith
Vice President, Site Head-Madison

Teams

This company has no teams yet